Published in
Wiley, British Journal of Haematology, 2(177), p. 254-262, 2017
DOI: 10.1111/bjh.14536
Links
Tools
Phase II study of bendamustine, bortezomib and dexamethasone (BBD) in the first-line treatment of patients with multiple myeloma who are not candidates for high dose chemotherapy
Journal article published in 2017 by
Jesus G. Berdeja,
Todd Bauer 
,
Edward Arrowsmith,
James Essell,
Patrick Murphy,
James A. Reeves,
Ralph V. Boccia,
William Donnellan,
Ian Flinn
,
Edward Arrowsmith,
James Essell,
Patrick Murphy,
James A. Reeves,
Ralph V. Boccia,
William Donnellan,
Ian Flinn
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 